Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Onur Baser"'
Publikováno v:
Journal of Medical Economics. 21:564-570
To examine the comorbidity and economic burden among moderate-to-severe psoriasis (PsO) and/or psoriatic arthritis (PsA) patients in the US Department of Defense (DoD) population.This retrospective cohort claims analysis was conducted using DoD data
Publikováno v:
Journal of Medical Economics. 16:1137-1145
To evaluate the real-world rates of hypoglycemia and related costs among patients with type 2 diabetes mellitus (T2DM) who initiated insulin glargine with either a disposable pen or vial-and-syringe.Pooled data were evaluated from six previously publ
Publikováno v:
Journal of medical economics. 19(12)
Non-adherence and non-persistence to anti-hyperglycemic agents are associated with worse clinical and economic outcomes in patients with type 2 diabetes. This study evaluated treatment persistence and adherence across newer anti-hyperglycemic agents
Publikováno v:
Journal of Medical Economics. 14:433-439
We identified the cost of care and clinical events using dipyridamole versus adenosine in pharmacological stress (ST)/single-photon-emission computed tomography (SPECT) myocardial perfusion testing.Commercial health plan members received adenosine or
Publikováno v:
Journal of Medical Economics. 14:576-583
To compare adherence, healthcare costs and utilization of valsartan/amlodipine single-pill combination (SPC) and angiotensin-receptor blocker/calcium-channel blocker multiple-pill free-combination (ARB + CCB FC) therapy using real-world data.A retros
Autor:
Onur Baser
Publikováno v:
Journal of Medical Economics. 10:379-391
SummaryThis study identified when regression adjustment fails to adjust adequately for differences in observed covariates and where propensity score matching is the only alternative.Multivariate analysis might fail to adjust for observed confounders
Publikováno v:
Journal of medical economics. 18(5)
This study aimed to compare real world healthcare costs and resource utilization between patients with schizophrenia treated with paliperidone palmitate long-acting injection (PP) and oral atypical antipsychotics (OAT).Patients (18-64 years) were sel
Publikováno v:
Journal of medical economics. 14(6)
To evaluate clinical and economic outcomes in patients with type 2 diabetes mellitus (T2DM) who failed oral anti-diabetic drug (OAD) therapy and initiated either insulin glargine with disposable pen (GLA-P) or exenatide BID (EXE).This retrospective s